International Journal of Antimicrobial Agents
Volume 35, Issue 5 , Pages 514-515 , May 2010

Potential of doripenem for the treatment of infections with multidrug-resistant Pseudomonas spp.

  • R. Naesens

      Affiliations

    • Corresponding Author InformationCorresponding author. Present address: Laboratory of Microbiology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium. Tel.: +32 3 285 29 57; fax: +32 3 285 29 48.
    • ,
  • H. Jansens
    • ,
  • H. Goossens
    • ,
  • M. Ieven

References 

  1. Fujimura T, Anan N, Sugimori G, Watanabe T, Jinushi Y, Yoshida I, et al. Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents. Int J Antimicrob Agents. 2009;34:523–528
  2. Zavascki AP, Goldani LZ, Li J, Nation RL. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother. 2007;60:1206–1215
  3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
  4. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M07-A8. Wayne, PA: CLSI; 2009.

PII: S0924-8579(10)00018-X

doi: 10.1016/j.ijantimicag.2010.01.003

International Journal of Antimicrobial Agents
Volume 35, Issue 5 , Pages 514-515 , May 2010

Article Tools